ASN is on a steady uptrend, from 1.7c to 2.3c in the last week, up and down 10% each day. Worth keeping a eye on as perhaps news is coming.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
